Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: Why molecular epidemiologists should think about enzyme expression

Carcinogenesis

Volumn 22, Issue 2, 2001, Pages 209-214

  Williams, J A ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ADENINE; AROMATIC AMINE; CARCINOGEN; CYTOCHROME P450; ENZYME; GUANINE; HETEROCYCLIC AMINE; ISOENZYME; LACTOPEROXIDASE; MYELOPEROXIDASE; PEROXIDASE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; SULFADIMIDINE; SULFOTRANSFERASE; TOBACCO SMOKE;

ACETYLATION; ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CATALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; COOKING; CYTOSOL; ENVIRONMENTAL FACTOR; ENZYME ASSAY; ENZYME MECHANISM; ENZYME SPECIFICITY; EPIDEMIOLOGY; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTOXICITY; HUMAN; LUNG CANCER; MEAT; METABOLIC ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0035117747     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.2.209     Document Type: Article

References (90)

1. Cancer prevention and diet: Help from single nucleotide polymorphisms
2. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer
3. Carcinogen-DNA adducts in human breast tissue
4. Genotoxicity of human mammary lipid
5. DNA adducts in human breast tissue: Association with N-acetyltransferase-2 (NAT2) and NAT1 genotypes
6. DNA damage in human breast milk cells and its induction by 'early' and 'late' milk extracts
7. Mammary expression of xenobiotic-metabolising enzymes and their potential role in breast cancer: A review
8. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today
9. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980
10. Environmental risk factors of breast cancer
11. Breast cancer and occupational exposures in women in Finland
12. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients
13. Inflammatory and immune processes in the human lung in health and disease: Evaluation by bronchoalveolar lavage
14. Myeloperoxidase in human lung lavage. II. Internalization of myeloperoxidase by alveolar macrophages
15. Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity
16. Assessment of chlorination by human neutrophils
17. Hypochlorous acid interactions with thiols, nucleotides, DNA and other biological substrates
18. Peroxidase-mediated irreversible binding of arylamine carcinogens to DNA in intact polymorphonuclear leukocytes activated by a tumor promoter
19. Oxidant-dependent metabolic activation of polycyclic aromatic hydrocarbons by phorbol ester-stimulated human polymorphonuclear leukocytes: Possible link between inflammation and cancer
20. Activation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to diolepoxides by human polymorphonuclear leukocytes or myeloperoxidase
21. Myeloperoxidase-enhanced formation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene-DNA adducts in lung tissue in vitro: A role of pulmonary inflammation in the bioactivation of a procarcinogen
22. Determination of the enzymes responsible for activation of the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline in the human breast
23. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element
24. Sequence comparison of putative regulatory DNA of the 5′ flanking region of the myeloperoxidase gene in normal and leukemic bone marrow cells
25. Myeloperoxidase genetic polymorphism and lung cancer risk
26. Association of the myeloperoxidase -463G→A polymorphism with lung cancer risk
27. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant-463A of the myeloperoxidase gene
28. Genetic variants of myeloperoxidase and lung cancer risk
29. Cancer Prevention and Early Detection, Facts and Figures 2000
30. Food heating and the formation of heterocyclic aromatic amine and polycyclic aromatic hydrocarbon mutagens/carcinogens
31. Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclic amines in cooked foods
32. The prostate: A target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods
33. Well-done meat intake and the risk of breast cancer
34. Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue
35. Interindividual variation in the metabolic activation of heterocyclic amines and their N-hydroxy derivatives in primary cultures of human mammary epithelial cells
36. DNA adducts of heterocyclic amine food mutagens: Implications for mutagenesis and carcinogenesis
37. Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts
38. N-acetyltransferase expression and metabolic activation of the food- derived heterocyclic amines in the human mammary gland
39. Human mammary NAT and SULT enzymes metabolically activate N-hydroxylated heterocyclic amines, but NAT enzyme activity is not influenced by NAT genotype
40. Human acetyltransferase polymorphisms
41. Sulfotransferase catalyzing sulfation of heterocyclic amines
42. Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms
43. N-acetyl transferase 2 genotypes, meat intake and breast cancer risk
44. Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype
45. Alkylation of intracellular and extracellular DNA by dimethylnitrosamine following activation by isolated rat hepatocytes
46. Tumorigenicity studies with diol-epoxides of benzo (a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha -epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice
47. Metabolism of benzo (a)pyrene by isolated hepatocytes and factors affecting covalent binding of benzo(a)pyrene metabolites to DNA in hepatocyte and microsomal systems
48. Metabolism of chemical carcinogens
49. The identification of [2-(14)C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans
50. Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative
51. The metabolism of 2-amino-3,8-dimethylimdiazo[4,5-f]quinoxaline in human hepatocytes
52. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans
53. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms
54. Sulfotransferase molecular biology: 1. cDNAs and genes
55. Bioactivation of mutagens via sulfation
56. Sulfotransferase-mediated activation of mutagens studied using heterologous expression systems
57. A 7-hydroxymethyl sulfate ester as an active metabolite of 7,12-dimethylbenz[a]anthracene
58. Factors determining dietary intakes of heterocyclic amines in cooked foods
59. Hepatic DNA and RNA adduct formation from the carcinogen 7-hydroxymethyl-12-methylbenz[a]anthracene and its electrophilic sulfuric acid ester metabolite in preweanling rats and mice
60. Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2
61. Phenol sulfotransferase pharmacogenetics in humans: Association of common SULT1A1 alleles with TS PST phenotype
62. Phenol sulphotransferase SULT1A1 polymorphisms: Molecular diagnosis and allele frequencies in Caucasian and African populations
63. Sulfotransferases: Genetics and role in toxicology
64. Heterocyclic amine content of cooked meat and risk of prostate cancer
65. Up-regulation of cytochrome P450 1A2, 2C9 and 2E1 in chronic pancreatitis
66. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis
67. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1
68. Detection of three genetic polymorphisms in the 5′-flanking region and intron 1 of human CYP1A2 in the Japanese population
69. Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine
70. Detailed modelling of caffeine metabolism and examination of the CYP1A2 gene: Lack of a polymorphism in CYP1A2 in Caucasians
71. A prospective study of cancer incidence in a cohort examined for allergy
72. Current concepts: Neutrophils and the activation of carcinogens in the breast and other organs
73. Bioactivation of the proximal food mutagen 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) to DNA-binding species by human mammary gland enzymes
74. Smoking and periductal mastitis
75. Molecular cloning and characterization of the chromosomal gene for human lactoperoxidase
76. The metabolism of 17 beta-estradiol by lactoperoxidase: A possible source of oxidative stress in breast cancer
77. Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine
78. N-acetyltransferases: The second phase
79. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe
80. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase
81. Macrolide antibiotics inhibit the degradation of the glucocorticoid-responsive cytochrome P450p in rat hepatocytes in vivo and in primary monolayer culture
82. Immunochemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder
83. Expression of arylamine N-acetyltransferase in human intestine
84. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines
85. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: Role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism
86. Stereoselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2 and epoxide hydrolase
87. Purification of human liver microsomal epoxide hydrase. Differences in the properties of the human and rat enzymes
88. Activation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to diolepoxides by human polymorphonuclear leukocytes or myeloperoxidase
89. Allergy and Cancer: Organ site-specific results from the Adventist Health Study